Mendell JR - Search Results

1

Facioscapulohumeral muscular dystrophy (FSHD): design of natural history study and results of baseline testing. FSH-DY Group.

Tawil R, McDermott MP, Mendell JR, Kissel J, Griggs RC. Tawil R, et al. Among authors: mendell jr. Neurology. 1994 Mar;44(3 Pt 1):442-6. doi: 10.1212/wnl.44.3_part_1.442. Neurology. 1994. PMID: 8145913

2

Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group.

Tawil R, Forrester J, Griggs RC, Mendell J, Kissel J, McDermott M, King W, Weiffenbach B, Figlewicz D. Tawil R, et al. Ann Neurol. 1996 Jun;39(6):744-8. doi: 10.1002/ana.410390610. Ann Neurol. 1996. PMID: 8651646

3

Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy.

Griggs RC, Miller JP, Greenberg CR, Fehlings DL, Pestronk A, Mendell JR, Moxley RT 3rd, King W, Kissel JT, Cwik V, Vanasse M, Florence JM, Pandya S, Dubow JS, Meyer JM. Griggs RC, et al. Among authors: mendell jr. Neurology. 2016 Nov 15;87(20):2123-2131. doi: 10.1212/WNL.0000000000003217. Epub 2016 Aug 26. Neurology. 2016. PMID: 27566742 Free PMC article. Clinical Trial.

4

Dystrophin expression and somatic reversion in prednisone-treated and untreated Duchenne dystrophy. CIDD Study Group.

Burrow KL, Coovert DD, Klein CJ, Bulman DE, Kissel JT, Rammohan KW, Burghes AH, Mendell JR. Burrow KL, et al. Among authors: mendell jr. Neurology. 1991 May;41(5):661-6. doi: 10.1212/wnl.41.5.661. Neurology. 1991. PMID: 1781820 Clinical Trial.

5

Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group.

Griggs RC, Moxley RT 3rd, Mendell JR, Fenichel GM, Brooke MH, Pestronk A, Miller JP. Griggs RC, et al. Among authors: mendell jr. Arch Neurol. 1991 Apr;48(4):383-8. doi: 10.1001/archneur.1991.00530160047012. Arch Neurol. 1991. PMID: 2012511 Clinical Trial.

6

Mononuclear cell analysis of muscle biopsies in prednisone-treated and untreated Duchenne muscular dystrophy. CIDD Study Group.

Kissel JT, Burrow KL, Rammohan KW, Mendell JR. Kissel JT, et al. Among authors: mendell jr. Neurology. 1991 May;41(5):667-72. doi: 10.1212/wnl.41.5.667. Neurology. 1991. PMID: 2027481 Clinical Trial.

7

A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy.

Fenichel GM, Mendell JR, Moxley RT 3rd, Griggs RC, Brooke MH, Miller JP, Pestronk A, Robison J, King W, Signore L, et al. Fenichel GM, et al. Among authors: mendell jr. Arch Neurol. 1991 Jun;48(6):575-9. doi: 10.1001/archneur.1991.00530180027012. Arch Neurol. 1991. PMID: 2039377 Clinical Trial.

8

Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy.

Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Florence J, King WM, Pandya S, Robison J, Schierbecker J, et al. Brooke MH, et al. Among authors: mendell jr. Neurology. 1989 Apr;39(4):475-81. doi: 10.1212/wnl.39.4.475. Neurology. 1989. PMID: 2927672

9

Genetic heterogeneity in Duchenne dystrophy.

Hyser CL, Province M, Griggs RC, Mendell JR, Fenichel GM, Brooke MH, Miller JP, Polakowska R, Doherty RA, Quirk S, et al. Hyser CL, et al. Among authors: mendell jr. Ann Neurol. 1987 Oct;22(4):553-5. doi: 10.1002/ana.410220420. Ann Neurol. 1987. PMID: 3435074

10

Genetics of facioscapulohumeral muscular dystrophy: new mutations in sporadic cases.

Griggs RC, Tawil R, Storvick D, Mendell JR, Altherr MR. Griggs RC, et al. Among authors: mendell jr. Neurology. 1993 Nov;43(11):2369-72. doi: 10.1212/wnl.43.11.2369. Neurology. 1993. PMID: 8232958

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

409 results

Search Page

Filters